Chris Chambers, MBA is the founder of The Einstein Bridge and The Turing Forge, as well as Principal of Chambers Capital Ventures, Inc. What we are witnessing at a macro level has huge implications, ...
Structure-Based Screening: The EDT uses a highly refined set of detailed, structure-based questions to classify chemicals into toxicity categories with greater specificity than the Cramer Decision ...